CYP2E1 and metabolic dysfunction-associated steatotic liver disease: Hepatic CYP2E1 activity is increased not only in NAFLD, as previously mentioned, but also in other pathophysiological states including alcoholic liver disease, malnutrition and diabetes [18,40].